PROTEAN.NS(PROTEAN.NS)
PROTEAN.NS
No analyst ratings available
No analyst price targets available for PROTEAN.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $11.61B | $12.54B |
| Low | $11.48B | $12.05B |
| High | $11.74B | $13.05B |
| EBITDA Avg | $2.09B | $2.26B |
| Low | $2.07B | $2.17B |
| High | $2.12B | $2.35B |
| EBIT Avg | $1.63B | $1.76B |
| Low | $1.61B | $1.69B |
| High | $1.65B | $1.83B |
| Net Income Avg | $1.29B | $1.40B |
| Low | $1.26B | $1.24B |
| High | $1.32B | $1.53B |
| EPS Avg | $31.70 | $34.40 |
| Low | $30.93 | $30.46 |
| High | $32.47 | $37.69 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 3 |